Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Epilepsy is a widespread neurological disorder characterized by recurring seizures that have a significant impact on individuals' lives. Accurately recognizing epileptic seizures is crucial for proper diagnosis and treatment. Deep learning models have shown promise in improving seizure recognition accuracy. However, optimizing their performance for this task remains challenging. This study presents a new approach to optimize epileptic seizure recognition using deep learning models. The study employed a dataset of Electroencephalography (EEG) recordings from multiple subjects and trained nine deep learning architectures with different preprocessing techniques. By combining a 1D convolutional neural network (Conv1D) with a Long Short-Term Memory (LSTM) network, we developed the Conv1D + LSTM architecture. This architecture, augmented with dropout layers, achieved an effective test accuracy of 0.993. The LSTM architecture alone achieved a slightly lower accuracy of 0.986. Additionally, the Bidirectional LSTM (BiLSTM) and Gated Recurrent Unit (GRU) architectures performed exceptionally well, with accuracies of 0.983 and 0.984, respectively. Notably, standard scaling proved to be advantageous, significantly improving the accuracy of both BiLSTM and GRU compared to MinMax scaling. These models consistently achieved high test accuracies across different percentages of Principal Component Analysis (PCA), with the best results obtained when retaining 50% and 90% of the features. Chi-square feature selection also enhanced the classification performance of BiLSTM and GRU models. The study reveals that different deep learning architectures respond differently to feature scaling, PCA, and feature selection methods. Understanding these nuances can lead to optimized models for epileptic seizure recognition, ultimately improving patient outcomes and quality of life.
Epilepsy is a widespread neurological disorder characterized by recurring seizures that have a significant impact on individuals' lives. Accurately recognizing epileptic seizures is crucial for proper diagnosis and treatment. Deep learning models have shown promise in improving seizure recognition accuracy. However, optimizing their performance for this task remains challenging. This study presents a new approach to optimize epileptic seizure recognition using deep learning models. The study employed a dataset of Electroencephalography (EEG) recordings from multiple subjects and trained nine deep learning architectures with different preprocessing techniques. By combining a 1D convolutional neural network (Conv1D) with a Long Short-Term Memory (LSTM) network, we developed the Conv1D + LSTM architecture. This architecture, augmented with dropout layers, achieved an effective test accuracy of 0.993. The LSTM architecture alone achieved a slightly lower accuracy of 0.986. Additionally, the Bidirectional LSTM (BiLSTM) and Gated Recurrent Unit (GRU) architectures performed exceptionally well, with accuracies of 0.983 and 0.984, respectively. Notably, standard scaling proved to be advantageous, significantly improving the accuracy of both BiLSTM and GRU compared to MinMax scaling. These models consistently achieved high test accuracies across different percentages of Principal Component Analysis (PCA), with the best results obtained when retaining 50% and 90% of the features. Chi-square feature selection also enhanced the classification performance of BiLSTM and GRU models. The study reveals that different deep learning architectures respond differently to feature scaling, PCA, and feature selection methods. Understanding these nuances can lead to optimized models for epileptic seizure recognition, ultimately improving patient outcomes and quality of life.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.